Comprehensive Postpartum Management for Women with Hypertensive Disorders of Pregnancy
妊娠期高血压疾病妇女的产后综合管理
基本信息
- 批准号:10708194
- 负责人:
- 金额:$ 22.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-21 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAffectAmerican College of Obstetricians and GynecologistsBirthBlack raceBlood PressureBlood Pressure MonitorsCardiovascular systemCaringCessation of lifeChronicClinicalCommunitiesConsentDiscipline of obstetricsDisparityDocumentationEclampsiaElectronic Health RecordFutureGuidelinesHELLP SyndromeHome Blood Pressure MonitoringHypertensionIndividualInterventionKidney FailureLegal patentMaternal HealthMaternal MortalityMaternal-fetal medicineMedicaidMedicalModelingMorbidity - disease rateMulticenter TrialsNurse MidwivesNursesOutcomeOutcome MeasureOutpatientsParameter EstimationParticipantPatient CarePatient Outcomes AssessmentsPatientsPhysiciansPopulationPostpartum HypertensionPostpartum PeriodPostpartum ProgramsPre-EclampsiaPregnancyPrimary CareProcessPulmonary EdemaRaceRandomizedRecommendationReportingRiskSocial WorkersSpecialistStressStrokeSurveysSystemTelemedicineTennesseeTimeWomanWorkblack patientblood pressure controlcare fragmentationcommunity engaged researchcommunity engagementdisparity reductionexperiencefollow-uphealth care service organizationhypertension controlimprovedintegrated caremedical vulnerabilitymultidisciplinarypatient engagementpeerperceived discriminationpost pregnancypostpartum carepregnancy disorderpregnancy hypertensionpregnancy related deathprimary care clinicianprimary care visitprimary outcomeprogramsracial disparityrandomized trialsatisfactionsecondary outcomesevere maternal morbiditytrial comparing
项目摘要
SUMMARY
Hypertensive disorders of pregnancy (HDP) - chronic hypertension, gestational hypertension, preeclampsia,
HELLP, and eclampsia - account for a substantial portion of severe maternal morbidity and mortality in the U.S.
and occur 2.5 times more frequently among Black compared to non-Black patients. The weeks after birth are
crucial for maternal health, especially considering that half of all pregnancy-related deaths occur postpartum.
The American College of Obstetricians and Gynecologists recently redefined postpartum care to encompass
12 months after birth and stressed the importance of connecting postpartum patients to primary care clinicians
to manage chronic medical conditions. This handoff is critical as 50% of patients with HDP develop chronic
hypertension, and patients with HDP have twice the risk of later cardiovascular-related death. In line with this
recommendation, Tennessee recently expanded Medicaid coverage to 12 months postpartum. Given that most
obstetric clinicians currently do not provide comprehensive primary care, we urgently need models for bridging
gaps in care after pregnancy especially for medically vulnerable patients. While interventions such as
telemedicine and peer navigation demonstrate promise to improve patient engagement in care and reduce
postpartum racial disparities, no randomized trials address system-level initiatives to improve postpartum care
for patients with HDP. We propose to build a comprehensive management program for postpartum patients
with HDP who are at risk of severe maternal morbidity and mortality. Using a community-engaged approach,
we will tailor this program to Black patients who represent a disproportionate share of those affected by
postpartum HDP. This program emphasizes three key components: 1) self-monitoring of blood pressures, 2)
blood pressure management navigation, and 3) facilitated transition to primary care clinicians for hypertension
management. Our multidisciplinary team, including maternal-fetal medicine specialists, certified nurse
midwives, program navigators, and social workers will accomplish our specific aims to: 1) conduct rigorous
patient engagement that identifies barriers and facilitators to postpartum hypertension care especially among
Black patients 2) conduct rigorous clinician engagement that uncovers barriers and facilitators to postpartum
hypertension management, and 3) perform a pilot randomized trial comparing usual postpartum care to our
comprehensive HDP management program. We hypothesize that our intervention will increase patient
engagement with blood pressure monitoring, identify more patients with severe-range blood pressures, and
reduce disparities in outcomes between Black and non-Black patients. Our work directly advances integrated
models of care using community-engaged research among populations who bear a disproportionate burden of
severe maternal morbidity and mortality. The results will produce stakeholder-informed outcomes and key
parameter estimates for conducting a robust multicenter trial.
总结
妊娠期高血压疾病(HDP)-慢性高血压、妊娠期高血压、先兆子痫,
HELLP和子痫-占美国严重孕产妇发病率和死亡率的很大一部分。
黑人患者的发病率是非黑人患者的2.5倍。出生后的几周是
这对孕产妇健康至关重要,特别是考虑到一半的妊娠相关死亡发生在产后。
美国妇产科学院最近重新定义了产后护理,
出生后12个月,并强调将产后患者与初级保健医生联系起来的重要性
来管理慢性疾病这种交接是至关重要的,因为50%的HDP患者发展为慢性
高血压患者的心血管相关死亡风险是高血压患者的两倍。根据这一
田纳西州最近将医疗补助覆盖范围扩大到产后12个月。鉴于大多数
产科临床医生目前不提供全面的初级保健,我们迫切需要模型的桥梁
怀孕后的护理差距,特别是对医学上脆弱的病人。虽然干预措施,如
远程医疗和同伴导航显示出改善患者参与护理和减少
产后种族差异,没有随机试验解决系统层面的举措,以改善产后护理
对于HDP患者。我们建议为产后病人建立一个全面的管理方案
患有HDP的妇女面临严重的孕产妇发病率和死亡率风险。采用社区参与的方法,
我们将为黑人患者量身定制这一计划,他们在受影响的患者中所占比例不成比例。
产后HDP。该计划强调三个关键组成部分:1)自我监测血压,2)
血压管理导航,以及3)促进向高血压初级保健临床医生的过渡
管理我们的多学科团队,包括母胎医学专家,注册护士
助产士,项目导航员和社会工作者将实现我们的具体目标:1)进行严格的
患者参与,确定产后高血压护理的障碍和促进因素,特别是在
黑人患者2)进行严格的临床医生参与,揭示产后障碍和促进因素
高血压管理,以及3)进行一项试点随机试验,比较常规产后护理与我们的
全面的HDP管理计划。我们假设我们的干预会增加病人
参与血压监测,发现更多血压范围严重的患者,
减少黑人和非黑人患者之间的结果差异。我们的工作直接推进综合
利用社区参与的研究,在承受不成比例的医疗负担的人群中建立护理模式,
产妇发病率和死亡率很高。结果将产生知情的结果和关键
进行稳健多中心试验的参数估计。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sarah Scheiderich Osmundson其他文献
Sarah Scheiderich Osmundson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sarah Scheiderich Osmundson', 18)}}的其他基金
Comprehensive Postpartum Management for Women with Hypertensive Disorders of Pregnancy
妊娠期高血压疾病妇女的产后综合管理
- 批准号:
10604847 - 财政年份:2022
- 资助金额:
$ 22.23万 - 项目类别:
Reducing Unused Prescribed Opioids After Cesarean Birth
减少剖腹产后未使用的处方阿片类药物
- 批准号:
10448490 - 财政年份:2019
- 资助金额:
$ 22.23万 - 项目类别:
Reducing Unused Prescribed Opioids After Cesarean Birth
减少剖腹产后未使用的处方阿片类药物
- 批准号:
10224161 - 财政年份:2019
- 资助金额:
$ 22.23万 - 项目类别:
Reducing Unused Prescribed Opioids After Cesarean Birth
减少剖腹产后未使用的处方阿片类药物
- 批准号:
10671569 - 财政年份:2019
- 资助金额:
$ 22.23万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 22.23万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 22.23万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 22.23万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 22.23万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 22.23万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 22.23万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 22.23万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 22.23万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 22.23万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 22.23万 - 项目类别:
Research Grant